IMMUNOCORE HLDGS PLC's ticker is IMCR and the CUSIP is 45258D105. A total of 87 filers reported holding IMMUNOCORE HLDGS PLC in Q3 2022. The put-call ratio across all filers is 5.07 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,311,825 | -10.6% | 25,276 | +3.3% | 0.18% | -3.2% |
| Q2 2023 | $1,466,862 | +45.5% | 24,464 | +20.0% | 0.19% | +13.3% |
| Q1 2023 | $1,008,131 | -17.5% | 20,391 | -4.7% | 0.17% | +44.3% |
| Q4 2022 | $1,221,356 | -4.2% | 21,401 | -21.2% | 0.12% | -8.0% |
| Q3 2022 | $1,275,000 | – | 27,171 | – | 0.12% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bill & Melinda Gates Foundation | 576,923 | $24,560,000 | 4.02% |
| Rock Springs Capital Management LP | 2,292,285 | $97,583,000 | 2.13% |
| RTW INVESTMENTS, LP | 1,245,532 | $50,142,000 | 0.78% |
| Avidity Partners Management LP | 550,000 | $23,414,000 | 0.65% |
| Samsara BioCapital, LLC | 80,000 | $3,406,000 | 0.63% |
| Bain Capital Public Equity Management II, LLC | 300,871 | $12,808,000 | 0.53% |
| GENERAL ATLANTIC, L.P. | 950,000 | $40,442,000 | 0.47% |
| Baker Brothers Advisors | 2,520,730 | $107,307,000 | 0.46% |
| Perceptive Advisors | 400,000 | $17,028,000 | 0.22% |
| Pinz Capital Management, LP | 18,700 | $796,000 | 0.21% |